Thermotherapy and thermoablation for benign prostatic hyperplasia.

Authors:
Stavros Gravas
Stavros Gravas
University Hospital of Larissa
Greece
Pilar Laguna
Pilar Laguna
University of Amsterdam

Curr Opin Urol 2003 Jan;13(1):45-9

Department of Urology, UMC St Radboud, 6500 HB Nijmegen, the Netherlands.

Purpose Of Review: From all the available thermoablative methods for the treatment of symptomatic benign prostatic hyperplasia, transurethral microwave thermotherapy is considered as standard in minimally invasive management. The literature is enriched by several new studies on transurethral microwave thermotherapy, and thus this review presents up-to-date information about thermotherapy.

Recent Findings: New studies have provided significant information regarding differences in outcome for devices with different protocols and selection criteria, confirming the superiority of high-energy programmes. Furthermore, monitoring of the intraprostatic temperature promises better clinical results by means of individualization of the treatment. Long-term results have been available and allow the evaluation of the fundamental issue of treatment durability. Improvement after high-energy transurethral microwave thermotherapy remains durable for more than 2.5 years. Randomized studies comparing this treatment with other established therapies for benign prostatic hyperplasia, including medical treatment and transurethral resection of the prostate, have also contributed to an evaluation of the morbidity, and costs of treatment. Clinical outcomes with transurethral microwave thermotherapy are in the range of those obtained with transurethral resection of the prostate and are superior to those of medical management. Retreatment after transurethral resection of the prostate emerges because of complications following the procedure, whereas retreatment after transurethral microwave thermotherapy is as a result of treatment failure. In addition, the rate of failure of medical management is almost seven times higher than that for transurethral microwave thermotherapy. Thus, the latter seems to play a dominant role in the economic models used to assess the cost-efficiency of different treatment modalities for benign prostatic hyperplasia.

Summary: The recent innovations in high-energy transurethral microwave thermotherapy provide better and more durable clinical outcomes and lower morbidity, and strengthen its position as an established treatment for benign prostatic hyperplasia. However, there is always room for improvement, so further research on therapeutic protocols, treatment monitoring and selection criteria are to be welcomed.

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.mou.0000049386.71470.98DOI Listing

Still can't find the full text of the article?

Sign up to send a request to the authors directly.
January 2003
9 Reads

Publication Analysis

Top Keywords

microwave thermotherapy
28
transurethral microwave
28
benign prostatic
20
prostatic hyperplasia
16
transurethral resection
12
resection prostate
12
treatment
10
transurethral
10
selection criteria
8
medical management
8
clinical outcomes
8
thermotherapy
8
retreatment transurethral
8
high-energy transurethral
8
microwave
7
prostatic
5
benign
5
thermotherapy provide
4
treatment modalities
4
randomized studies
4

Similar Publications